121 related articles for article (PubMed ID: 538065)
1. Influence of tiadenol, bis-(hydroxyethylthio)1,10-decane, on cholesterol metabolism in rats.
Kritchevsky D; Tepper SA; Czarnecki SK; Story JA
Pharmacol Res Commun; 1979 Nov; 11(10):861-7. PubMed ID: 538065
[No Abstract] [Full Text] [Related]
2. [Comparative effects of clofibrate and tiadenol on the metabolism of cholesterol in rats. II. Comparative action of clofibrate and tiadenol on biliary and fecal excretion of cholesterol and its metabolites in rats].
Fredj G; Clenet M; Rousselet F
Ann Pharm Fr; 1986; 44(5):347-54. PubMed ID: 3579157
[No Abstract] [Full Text] [Related]
3. [Comparative effects of clofibrate and tiadenol on the metabolism of cholesterol in rats and hamsters. I. Comparative action of clofibrate and tiadenol on hepatic and intestinal biosynthesis of cholesterol in hamsters and rats].
Rousselet F; Fredj G; Clenet M
Ann Pharm Fr; 1986; 44(4):269-76. PubMed ID: 3566092
[No Abstract] [Full Text] [Related]
4. Action of tiadenol and clofibrate on biliary excretions of cholesterol and bile salts in rats.
Fredj G; Clenet M; Cuchet P; Rousselet F; Rozé C
Digestion; 1979; 19(4):228-36. PubMed ID: 478204
[TBL] [Abstract][Full Text] [Related]
5. The effects of tiadenol, clofibrate and clofibride on bile composition in the rat.
Rozé C; Cuchet P; Souchard M; Vaille C; Debray C
Eur J Pharmacol; 1977 May; 43(1):57-64. PubMed ID: 862664
[TBL] [Abstract][Full Text] [Related]
6. Experimental studies on pharmacology, metabolism and toxicology with tiadenol-disulfoxide. Dissociation of lipid lowering effects and the induction of peroxisomal and microsomal drug-metabolizing enzymes.
Maffei Facino R; Carini M; Tofanetti O; Casciarri I; Longoni E
Arzneimittelforschung; 1987 Jun; 37(6):682-91. PubMed ID: 3663266
[TBL] [Abstract][Full Text] [Related]
7. Changes in lipid metabolizing enzymes of hepatic subcellular fractions from rats treated with tiadenol and clofibrate.
Berge RK; Bakke OM
Biochem Pharmacol; 1981 Aug; 30(16):2251-6. PubMed ID: 7295339
[No Abstract] [Full Text] [Related]
8. Antilipolytic effect of tiadenol and clofibrate in rat epididymal fat pads.
Bacciarelli C; Boni P; Castellucci A
Farmaco Prat; 1978 Sep; 33(9):401-6. PubMed ID: 218836
[No Abstract] [Full Text] [Related]
9. Effects of clofibrate and tiadenol on the elimination of lipids and bile acids in rat bile.
Cuchet P; Morrier C; Cand F; Keriel C
Lipids; 1981 Oct; 16(10):732-8. PubMed ID: 7300592
[TBL] [Abstract][Full Text] [Related]
10. [The action of tiadenol on compensatory hypertrophy of the liver in the rat].
Rozé C; Vaille C; Souchard M; De la Tour J; Debray C
Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):166-76. PubMed ID: 984967
[TBL] [Abstract][Full Text] [Related]
11. Effect of SaH 42-348, an analog of clofibrate, on lipid metabolism in rats.
Kritchevsky D; Tepper SA
Arzneimittelforschung; 1973 Jun; 23(6):858-9. PubMed ID: 4740771
[No Abstract] [Full Text] [Related]
12. Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. I. The effect of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in normal rats.
Tomita T; Takeshita R; Nagakura T; Hayashi E
Jpn J Pharmacol; 1973 Jun; 23(3):281-7. PubMed ID: 4541943
[No Abstract] [Full Text] [Related]
13. [Inducing effects of bis-hydroxyethylthio-1,10-decane (tiadenol) on hepatic microsomal enzymes of the rat].
Mounie J; Goudonnet H; Bereksi-Reguig K; Escousse A; Truchot R
J Pharmacol; 1983; 14(2):171-82. PubMed ID: 6408317
[TBL] [Abstract][Full Text] [Related]
14. The application of a simple method to determine the mode of action of oral antihypercholesteremic drugs.
Brandau K; Schlossmann K
Arzneimittelforschung; 1974 Oct; 24(10):1535-42. PubMed ID: 4479759
[No Abstract] [Full Text] [Related]
15. On the mechanism of hypocholesterolemic effects of polyunsaturated lipids.
Paul R; Ramesha CS; Ganguly J
Adv Lipid Res; 1980; 17():155-71. PubMed ID: 6992526
[No Abstract] [Full Text] [Related]
16. Pharmacological studies on tiadenol in type IV patients. Evidence for a mechanism of action different from other lipid-lowering drugs.
Franceschini G; Poli A; Catapano AL; Gatti E; Sirtori M; Gianfranceschi G; Sirtori CR
Atherosclerosis; 1981; 40(3-4):245-55. PubMed ID: 7332603
[TBL] [Abstract][Full Text] [Related]
17. Lipid lowering influence of ethyl p-chlorophenoxyisobutyrate in liver of rats fed high fat diets.
Kokatnur MG; Malcom GT
Metabolism; 1970 Feb; 19(2):120-8. PubMed ID: 5410942
[No Abstract] [Full Text] [Related]
18. [Mechanism of action of clofibrate].
Lang PD
Ther Ggw; 1975 Feb; 114(2):204-6, 208-10, 212-4. PubMed ID: 1118816
[No Abstract] [Full Text] [Related]
19. [Regulation of cholesterol synthesis in the rat liver under the influence of serum cholesterol-decreasing drugs].
Kaiser W; Zöllner N
Verh Dtsch Ges Inn Med; 1972; 78():1307-10. PubMed ID: 4665529
[No Abstract] [Full Text] [Related]
20. Effects of clofibrate, cholestyramine, zanchol, probucol, and AOMA feeding on hepatic and intestinal cholesterol metabolism and on biliary lipid secretion in the rat.
Turley SD; Dietschy JM
J Cardiovasc Pharmacol; 1980; 2(3):281-97. PubMed ID: 6156326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
